60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) on Friday, soared 8.46% from the previous trading day, before settling in for the closing price of $1.3. Within the past 52 weeks, SXTP’s price has moved between $1.22 and $12.45.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 12.29%. The company achieved an average annual earnings per share of 75.84%. With a float of $3.98 million, this company’s outstanding shares have now reached $4.10 million.
60 Degrees Pharmaceuticals Inc (SXTP) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of 60 Degrees Pharmaceuticals Inc is 3.02%, while institutional ownership is 6.96%. The most recent insider transaction that took place on Jun 03 ’25, was worth 14,410. In this transaction Director of this company bought 5,000 shares at a rate of $2.88, taking the stock ownership to the 15,816 shares. Before that another transaction happened on Dec 13 ’24, when Company’s Director bought 6,000 for $1.56, making the entire transaction worth $9,375. This insider now owns 52,078 shares in total.
60 Degrees Pharmaceuticals Inc (SXTP) Earnings and Forecasts
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -4.34 earnings per share (EPS) for the period topping the consensus outlook (set at -4.35) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.12 per share during the current fiscal year. According to the Wall Street analysts, stocks earnings will be around 75.84% per share during the next fiscal year.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Trading Performance Indicators
60 Degrees Pharmaceuticals Inc (SXTP) is currently performing well based on its current performance indicators. A quick ratio of 1.80 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -11.31, a number that is poised to hit -1.21 in the next quarter and is forecasted to reach -5.36 in one year’s time.
Technical Analysis of 60 Degrees Pharmaceuticals Inc (SXTP)
Looking closely at 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP), its last 5-days average volume was 0.11 million, which is a drop from its year-to-date volume of 1.0 million. As of the previous 9 days, the stock’s Stochastic %D was 56.31%.
During the past 100 days, 60 Degrees Pharmaceuticals Inc’s (SXTP) raw stochastic average was set at 6.08%, which indicates a significant decrease from 90.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0729 in the past 14 days, which was lower than the 0.2622 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6774, while its 200-day Moving Average is $3.1009. However, in the short run, 60 Degrees Pharmaceuticals Inc’s stock first resistance to watch stands at $1.4702. Second resistance stands at $1.5304. The third major resistance level sits at $1.6305. If the price goes on to break the first support level at $1.3099, it is likely to go to the next support level at $1.2098. Should the price break the second support level, the third support level stands at $1.1496.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Key Stats
Market capitalization of the company is 5.79 million based on 4,104K outstanding shares. Right now, sales total 680 K and income totals -7,950 K. The company made 310 K in profit during its latest quarter, and -1,730 K in sales during its previous quarter.
